Overview
NSCLC is the most common type of lung cancer, making up 85% of cases. It grows slower than small cell lung cancer.
Symptoms
- •Persistent cough
- •Shortness of breath
- •Chest pain
- •Coughing up blood
- •Unexplained weight loss
- •Fatigue
Stages
Stage IAStage IBStage IIAStage IIBStage IIIAStage IIIBStage IV
Diagnosis
- ✓Low-dose CT scan
- ✓Chest X-ray
- ✓PET-CT
- ✓Bronchoscopy
- ✓Biopsy
- ✓Molecular testing (EGFR, ALK, ROS1, PD-L1)
Treatments
- →Surgery (lobectomy, segmentectomy)
- →Radiation therapy
- →Chemotherapy
- →Immunotherapy (pembrolizumab, nivolumab)
- →Targeted therapy (osimertinib, alectinib)
Risk Factors
⚠️Smoking
⚠️Secondhand smoke
⚠️Radon exposure
⚠️Asbestos
⚠️Family history
Key Facts
- ℹ️5-year survival: 63% (Stage I), 6% (Stage IV)
- ℹ️EGFR mutation common in non-smokers
- ℹ️Annual low-dose CT recommended for ages 50-80 with smoking history
ICD-10: C34.9 | Prevalence: çok yaygın
Last updated: 11/9/2025